Gefitinib Dhexdhexaad CAS 199327-61-2 daahirnimo>99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha ugu horreeya ee 7-Methoxy-6- (3-Morpholin-4-ylpropoxy) quinazolin-4 (3H) - Hal (CAS: 199327-61-2) oo leh tayo sare, dhexdhexaad ah. ee Gefitinib (CAS: 184475-35-2).Kiimikada Ruifu waxay bixin kartaa gaarsiinta adduunka oo dhan, qiimo tartan ah, adeeg aad u wanaagsan, tiro yar iyo tiro badan oo la heli karo.Iibso Gefitinib Dhexdhexaadiyeyaasha,Please contact: alvin@ruifuchem.com
| Magaca Kiimikada | 7-Methoxy-6-(3-Morpholin-4-ylpropoxy)quinazolin-4(3H)-Hal |
| La mid ah | 7-Methoxy-6- (3-Morpholinopropoxy) quinazolin-4 (3H) -Hal;7-Methoxy-6-[3- (4-Morpholinyl) propoxy] -4 (3H) -Quinazolinone;7-Methoxy-6-(3-Morpholinopropoxy)quinazolin-4-Hal |
| wasakhnimo | Nijaasta Gefitinib 5;Gefitinib EP wasakh A |
| Heerka Saamiyada | Suuqa dhexdiisa, Wax-soo-saarka Ganacsiga |
| Lambarka CAS | 199327-61-2 |
| Qaanuunka molecular | C16H21N3O4 |
| Miisaanka Molecular | 319.36 g/mol |
| Meesha dhalaalaysa | 242.0 ~ 247.0 ℃ |
| Cufnaanta | 1.32± 0.10 g/cm3 |
| COA & MSDS | La heli karo |
| Asal ahaan | Shanghai, Shiinaha |
| Summada | Kiimikada Ruifu |
| Walxaha | Heerarka Kormeerka | Natiijooyinka |
| Muuqashada | Caddaan ilaa budo cad-cad | U hogaansama |
| Meesha dhalaalaysa | 242.0 ~ 247.0 ℃ | 243.6 ~ 244.5 ℃ |
| Khasaare xagga qalajinta | <0.50% | 0.15% |
| Hadhaaga dabka | <0.20% | 0.11% |
| Xumaanta Keliya | <0.50% | <0.30% |
| Wadarta wasakhda | <1.00% | 0.30% |
| Daahirnimada / Habka Falanqaynta | >99.0% (HPLC) | 99.7% |
| 1H NMR Spectrum | Waafaqsan Qaab-dhismeedka | U hogaansama |
| Gabagabo | Alaabtu waa la tijaabiyay oo waafaqday tilmaamihii la bixiyay | |
| Codsiga | Dhexdhexaadka Gefitinib (CAS: 184475-35-2) | |
Xidhmada:Dhalada fluorinated, bacda bireed aluminium, 25kg/Drum kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Weelka si adag u xidh oo ku kaydi qabow, qalalan (2 ~ 8 ℃) iyo bakhaar hawo wanaagsan leh oo ka fog walxaha aan ku habboonayn.Ka ilaali iftiinka iyo qoyaanka.
Rarida:Ku gaarsii adduunka oo dhan hawo, by FedEx/DHL Express.Bixi keenid degdeg ah oo la isku halayn karo.
Sidee loo Iibsadaa?Fadlan la xidhiidhDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Khibrad 15 Sano ah?Waxaan leenahay in ka badan 15 sano oo waayo-aragnimo ah oo ku saabsan soo saarista iyo dhoofinta ee tiro balaadhan oo ah dhexdhexaad ah daawooyinka tayada sare leh ama kiimikooyinka ganaax.
Suuqyada Waaweyn?Iibiya suuqa gudaha, Waqooyiga Ameerika, Yurub, Hindiya, Kuuriya, Jabbaan, Australia, iwm.
Faa'iidooyinka?Tayada sare, qiimo jaban, adeegyo xirfadeed iyo taageero farsamo, gaarsiin degdeg ah.
TayadaHubinta?Nidaamka xakamaynta tayada adag.Qalabka xirfadlayaasha ah ee falanqaynta waxaa ka mid ah NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Imtixaanka xadka Microbial, iwm.
Tusaalooyinka?Badeecadaha intooda badani waxay bixiyaan muunado bilaash ah oo loogu talagalay qiimeynta tayada, kharashka dhoofinta waa in ay bixiyaan macaamiisha.
Hantidhawrka Warshada?Hantidhawrka warshada soo dhawoow.Fadlan horay u sii ballan.
MOQ?Ma jiro MOQ.Dalabka yar waa la aqbali karaa.
Waqtiga dirida? Haddii ay ku jirto kaydka, dammaanad bixinta saddex maalmood ah.
Gaadiidka?By Express (FedEx, DHL), hawada, badda.
Dukumentiyada?Adeegga iibka kadib: COA, MOA, ROS, MSDS, iwm waa la bixin karaa.
Isku-dhafka gaarka ah?Waxay ku siin kartaa adeegyada isku-dhafka gaarka ah si ay ugu habboonaato baahiyahaaga cilmi-baarista.
Shuruudaha Lacag-bixinta?Qaansheegga Proforma ayaa marka hore la soo diri doonaa ka dib marka la xaqiijiyo dalabka, oo lagu soo lifaaqay macluumaadka bangigayaga.Lacag bixinta T/T (Telex Transfer), PayPal, Western Union, iwm.
7-Methoxy-6-(3-Morpholin-4-ylpropoxy)quinazolin-4(3H) -Hal (CAS: 199327-61-2) waa dhexdhexaad / wasakhnimo Gefitinib (CAS: 184475-35-2).Gefitinib waa daawo daaweyneed oo gaar ah oo ka hortagta burooyinka oo ay soo saartay AstraZeneca, UK.Gefitinib waa daawada ugu horraysa ee la bartilmaameedsado molecular ee loogu talagalay daawaynta kansarka sambabada unugyada aan yarayn.Waxay u shaqeysaa iyada oo si xushmad leh u joojinaysa dariiqa wareejinta calaamadaha ee tayrosine kinase factor koritaanka epidermal (EGFR-TK).Bishii Agoosto 2002, Gefitinib waxaa markii ugu horreysay lagu suuq geeyey Japan sidii daawaynta safka koowaad ee kansarka sambabada unugyada yaryar ee hoos yimaada magaca ganacsiga Iressa.Bishii Maajo 2003, Maamulka Cunnada iyo Dawooyinka ee Mareykanka ayaa oggolaaday Gefitinib inuu yahay daweynta safka saddexaad ee monotherapy ee bukaannada qaba kansarka sambabada unugyada aan yareyn ee horumarsan kuwaas oo aan waxtar u lahayn dawooyinka kansarka ee platinum-ku-saleysan iyo daaweynta kiimoterabiga docetaxel.Waqtigan xaadirka ah, Gefitinib waxaa ansixiyay Australia, Japan, Argentina, Singapore iyo South Korea si loogu daweeyo kansarka sambabada unugyada yaryar ee horumarsan.Febraayo 28, 2005, Maamulka Cunnada iyo Dawooyinka ee Shiinaha ayaa oggolaaday Gefitinib si loogu daweeyo kansarka sambabada unugyada aan unugyada yaryarayn ee maxalliga ah ama metastatic (NSCLC) oo hore u qaatay kiimoterabi.Hadda looma ogola in loo isticmaalo daawaynta safka kowaad ee NSCLC sare.Bishii Luulyo 1, 2009, Hay'adda Daawooyinka Yurub waxay si rasmi ah u ansixisay Gefitinib ee safka koowaad, laynka labaad iyo daawaynta safka saddexaad ee kansarka sanbabada unug yar ee gudaha ama metastatic oo leh isbeddellada hidda-wadaha EGFR ee dadka waaweyn.
